Close Menu

NEW YORK – Waters reported before the opening of the market on Tuesday that its second quarter revenues were flat year over year, though the company noted that it expects new product introductions and improving end markets will drive growth in the second half of 2019.

For the three months ended June 29, the company posted Q2 revenues of $599.2 million, up less than 1 percent from $596.2 million in Q2 2018, and short of the average Wall Street estimate of $601.4 million. Foreign currency translation depressed revenues by 2 percent, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The first reported coronavirus cases in Europe and the US might not be related to the subsequent outbreaks in those areas, according to the New York Times.

According to NPR, there's a growing shortage of machines to run SARS-CoV-2 tests.

The Wall Street Journal and Kaiser Health News report that antibody testing for SARS-CoV-2 has led to further confusion.

In Nature this week: the largest known collection of human genetic variants, and more.

Jun
02
Sponsored by
NanoString

Core facilities support a broad range of scientific studies and must constantly integrate new technologies and analysis to underpin their users’ research. Areas for development include higher multiplex capabilities, greater quantification, correlation to other tools, as well as multi-omics.